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Background: Diabetes mellitus is one of the metabolic disorders that impede normal steps of wound
healing process. Worldwide, 15% of the 200 million diabetics suffer from diabetic wounds. Diabetic
complications, such as foot ulcer, impose major public health burdens worldwide.
Objective: The present study was carried out to evaluate comparative efﬁcacy of polyherbal creams with
framycetin sulfate cream on diabetic rats using incision and excision wound models.
Materials and methods: Alloxan (120 mg/kg, intraperitoneal) induced diabetic rat models (incision and
excision models) were used to evaluate wound healing effect of cream A, B, and framycetin sulfate. Cream
A and B were applied for a period of 10 and 20 days for incision and excision wound models, respectively.
Incision wound model was used to assess the effect on breaking strength. Wound contraction and
epithelialization period were measured using excision wound model. The data were analyzed by one-
way ANOVA followed by Bonferroni post-test.
Results: Tensile strength of the animals treated with cream B (941.66 ± 15.36) was found to be signiﬁ-
cantly greater (P < 0.001) as compared to tensile strength of the animals treated with cream A
(825 ± 22.36). Wound treated with cream B was found to heal signiﬁcantly (P < 0.001) faster (day 17) as
compared to wounds treated with framycetin sulfate (day 21).
Conclusions: Cream B was found to be more effective wound healing agent than cream A and framycetin
sulfate cream in treating diabetic wounds.
© 2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Awound is deﬁned as loss or breaking of cellular, anatomical, or
functional continuity of living tissues [1]. It is a clinical entity, is as
old as human, and is often considered as major problem in clinical
practice. Healing of wounds involve the activity of an intricate
network of blood cells, cytokines, and growth factors which ulti-
mately leads to the restoration of the injured skin or tissue to
normal condition. The classic model of wound healing is divided
into three sequential phases: Inﬂammatory phase (consisting of, C. U. Shah College of Phar-
mbai 400 049, Maharashtra,
ary University, Bangalore.
lore and World Ayurveda Foundat
es/by-nc-nd/4.0/).hemostasis and inﬂammation), proliferative phase (consisting of
granulation, contraction, and epithelialization), and remodeling
phase, which organizes structure with increased tensile strength
[2]. Though healing process takes place by itself and does not
require much help, various physiologic and mechanical factors,
such as poor nutrition, insufﬁcient oxygenation, infection, pro-
longed inﬂammation, age, diabetes and other diseases, drugs,
smoking, alcoholism, depression, and other factors [3] may impair
the healing response, resulting in a chronic wound that fails to
proceed through the usual stepwise progression.
Diabetes mellitus constitutes one of the most important public
health problems due to its high prevalence and enormous social
and economic consequences [4]. Delayed cutaneous wound healing
is a chronic complication in diabetic patients and is caused pri-
marily by hyperglycemia, prolonged inﬂammatory phase, defected
angiogenesis, diminished expression of cytokines, oxidative stress,
vascular insufﬁciency, and microbial infections [5e8]. Severalion. Publishing Services by Elsevier B.V. This is an open access article under the CC
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extract
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atherosclerosis, and foot deformities contribute to the severity of
the disease and in the development of chronic wounds in diabetic
patients that might be complicated leading to ulceration, necrosis,
and amputation [5,7]. Diabetes mellitus is life-threatening and
becomes the third largest killer of humans after cancer and car-
diovascular diseases, even with the use of several recent synthetic
drugs for effective treatment options [9].
Healing impairment of diabetic patients is still a serious clinical
problem for physicians worldwide due to unclear etiology Hence,
impairedwound healing in diabetics has caught the attention of the
world to help promote healing process and prevent the rising
complications. A new era in wound healing research is required,
involving new treatment strategies to deal with this emerging
issue. One of these is the use of medicinal plants as a source for
natural products to explore new therapeutic agents/tools intended
for diabetic wound management and treatment.
India has a rich tradition of plant-based knowledge on healthcare.
Many Ayurvedic plants have a very important role in the process of
wound healing. A large number of plants, plant extracts, decoctions,
orpastes are equally usedby tribals and folklore traditions in India for
the treatment of cuts, wounds, and burns [10]. Plants are potent
healers because they promote the repair mechanisms in a natural
way [11]. The phytomedicines are safe, effective, and relatively cheap
options for wound healing [12]. These natural agents induce healing
and regeneration of the lost tissue by multiple mechanisms such as
coagulation, disinfections, debridement, antioxidant, and provide
suitable environment for natural healing process [3].
Literature survey revealed that many plants are known to have
antioxidant, antimicrobial, anti-inﬂammatory, and wound healing
properties for example, Aloe vera, turmeric, and neem [13]. We
searched for such medicinal plants from Ayurvedic literature and
followed the reverse pharmacology path. This led us to the short-
listing of plant materials from almost 200 different options.
The present study was carried out to evaluate comparative ef-
ﬁcacy viz., cream A (Ari's Wound Healing Cream) and cream B
(Amarantha Wound Healing Cream) with framycetin sulfate cream
in diabetic wounds. Cream A was prepared using extracts of eight
herbs viz., Glycyrrhiza glabra, Ficus infectoria, Shorea robusta, Cur-
cuma longa, Berberis aristata, Rubia cordifolia, Azadirachta indica,
Pongamia glabra, and Yashad Bhasma as classical Ayurvedic prep-
aration. Cream B was prepared using Jatyadi Oil and classical Ay-
urvedic preparation, Yashad Bhasma and extracts of seven herbs
viz., Ficus religiosa, Ficus bengalensis, Centella asiatica, S. robusta, G.
glabra, A. indica, and P. glabra. Cream A differs from cream B in the
form of quantity and types of ingredients used in the formulations.
The major differentiating factors between the two creams are the
presence of Jatyadi Oil and Mandukparni extract in cream B.
Furthermore, the percentage of Yashad Bhasma in cream B is more
than cream A. Both the creams have Vranaropak properties.
The selected ingredients of both formulations were reported to
have signiﬁcant antimicrobial, antioxidant, wound healing, and anti-
inﬂammatory properties. The literature survey scientiﬁcally revealed
the use of Jatyadi Oil in the management of wounds [14]. Yashad
Bhasma is a classical Ayurvedic formulationwhich plays a signiﬁcant
role in protein synthesis, cell division, wound healing. It is known to
have antiseptic and astringent properties [15]. The plant ingredients
such as C. longa, B. aristata, A. indica, P. Glabra, and S. robusta possess
antimicrobial and wound healing properties [16]. The plant in-
gredients such as F. religiosa and F. bengalensis help to constrict and
heal the wounds due to their astringent property [17,18]. Few herbs
such as C. asiatica have ability to heal the wounds by increasing syn-
thesis of collagen and intracellular ﬁbronectin content [19]. G. glabra
has also beenused in the treatment ofwounds, ulcers, and burns [20].The growing popularity of natural and herbal medications, easy
availability of raw materials, cost-effectiveness, and paucity of re-
ported adverse reaction, prompted us to assess wound healing ef-
ﬁcacy of two Ayurvedic topical creams in comparison with
framycetin sulfate cream.2. Materials and methods
2.1. Materials
Cream A and B were developed and supplied by Ari Healthcare
Pvt. Ltd., Pune.
Composition of cream A (Ari's Wound Healing Cream):Composition of cream B (Amarantha Wound Healing Cream):
Each gram of cream contains percent of ingredients (w/w).2.2. Experimental animals
Albino Wistar rats of both sexes weighing 180e200 g were
used for the study. The animals were procured from Haffkine
Biopharmaceuticals, Mumbai. All animals were housed in poly-
propylene cages under standard experimental conditions with
26 ± 2 C ambient temperature and 12 h lightedark cycle. The
animals were fed standard pellet diet and were provided water ad
libitum. All experimental protocols were approved by the Institu-
tional Animal Ethics Committee (CUSCP/IAEC/27/2011-12) of C.U.
Shah College of Pharmacy, Santacruz (W), Mumbai, India.
Table 1
Effect of topical application of cream A, B, and framycetin sulfate cream on tensile
strength of the skin having incision wound in diabetic rat model.
Group Tensile strength (g)±SEM
I 825 ± 22.36
II 941.66 ± 15.36***
III 920.83 ± 10.04**
Data were expressed as means ± SEM for six rats in each group. The treated groups
were compared by one-way ANOVA with post-test. **P < 0.01, ***P < 0.001 versus
cream A. Group I: Cream A treated group, Group II: Cream B treated group, and
Group III: Framycetin sulfate treated group, SEM: Standard error of mean.
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To evaluate the safety of cream A and B, skin irritation study was
conducted on albino rats as per OECD guide lines number 404
(OECD, 2004). Twenty four hours before application of the sample,
the back of the albino rats was shaved carefully to remove the fur.
Cream A and B were applied on the skin patches of albino rats, and
the site of application in terms of erythema and edema was
examined at 24, 48, and 72 h for changes in any dermal reactions.
The irritation index was calculated to assess the irritation potential
of cream A and B according to Draize Test [21].
2.4. In vivo evaluation of wound healing activity
2.4.1. Induction of diabetes
Albino rats were weighed, and their fasting blood glucose levels
were determined before inducing diabetes. The animals were then
injected with single dose of alloxan (120 mg/kg, intraperitoneal).
Fasting blood glucose levels were measured 3 days later to conﬁrm
the diabetic status of the animals. For blood glucose measurements,
blood was withdrawn from the tail vein. Rats having blood sugar
level above 250 mg/dl, were selected for study.
2.5. Grouping of animals
Animals were randomized into four groups of six animals each.
The animals of Group I, II, and III were treated with topical appli-
cation of cream A, B, and standard framycetin sulfate, respectively.
For both excision and incision wound models, the animal groups
were classiﬁed and treated in the same manner.
2.6. Incision wound model
Animals were anesthetized by ether before wound creation. The
particular skin area was shaved using hair removal cream, Veet
(manufactured by Reckitt Benckiser [India] Ltd., New Delhi) 1 day
prior to the experiment. Incision of 6 cmwasmade through the skin
and cutaneous muscles using sterile scissors and forceps. The
incision was then closed with interrupted sutures with stitches
1 cm apart using sterile absorbable sutures. Black surgical thread
and curved needle number 19 were used for stitching the wound.Table 2
Effect of topical application of cream A, B, and framycetin sulfate cream on percent woun
Groups Days after wounding
4 8 12
Percentage of wound contraction
I 48.70 ± 1.76 66.67 ± 4.27 88.37 ± 0.83*
II 48.47 ± 2.36 77.03 ± 3.09 92.0 ± 0.59**
III 27.20 ± 3.29 63.33 ± 3.81 82.90 ± 2.26
Data were expressed as means ± SEM for six rats in each group. The treated groups were c
standard. Group I: Cream A treated group, Group II: Cream B treated group, and Group ICream A, B, and standard (framycetin sulfate) were topically
applied once a day. The sutures were then removed on the 8th day
post-wounding, and the tensile strength of 10-day old wound was
measured by tensiometer [22].
2.7. Excision wound model
Animals were anesthetized before wound creation by open
mask method using ether. The particular skin area was shaved
using hair removal cream (Veet) 1 day prior to the experiment. A
full thickness of the excisionwound of circular area (approximately
500 mm2), and 2 mm depth was made on the shaved back of the
rats. The wound was left undressed to the open environment.
Cream A, B, and standard (framycetin sulfate) were topically
applied once a day, starting from day 0 until complete epithelial-
ization. The parameters studied were percent wound closure and
epithelialization time. Wound closure was measured as a percent
contraction in wound area in each 4 days over a period of 30 days.
Wound closure was studied by tracing the raw wound using
transparent paper, and a permanent marker on every 4th day for
16 days. Wound area was measured by retracing the wound on a
millimeter scale graph paper. The period of epithelization was
calculated as the number of days required for falling off of the dead
tissue remnants without any residual raw wound [23].
2.8. Statistical analysis
Results were expressed as mean ± standard error of the mean
(SEM). Comparisons between the groups were performed using one-
way ANOVAwith post-test on GraphPad Instat 3 statistical software.
Differences were considered signiﬁcant, if P value is < 0.05, 0.01, and
0.001.
3. Results
3.1. Safety evaluation (skin irritation study)
There were no signs of redness and itching when cream A and B
were applied on the shaved back of albino rats. The primary skin
irritation index of the creams was calculated as 0.00. This indicates
that cream A and B were found to be safe.
3.2. Incision wound model
The results were presented as mean weight in gram ± SEM
required to open the sutured wounds [Table 1]. Tensile strength of
the wound in the animals treated with cream B and framycetin
sulfate cream was found to be signiﬁcantly higher (P < 0.001 and
P < 0.01, respectively) as compared to the tensile strength of the
wounds in animals treated with cream A. Tensile strength of the
wounds in the animals treated with cream B was found to be
greater as compared to tensile strength of the wounds in animalsd contraction and epithelialization period of excision wound in diabetic rat model.
16 20 Epithelialization period (days)
95.43 ± 0.53* 100 19.17 ± 0.31
96.60 ± 1.16** 100 17.00 ± 0.37***
92.00 ± 0.85 100 20.50 ± 0.43
ompared by one-way ANOVAwith post-test. *P < 0.05, **P < 0.01, ***P < 0.001 versus
II: Framycetin sulfate treated group, SEM: Standard error of mean.
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weight and more strength were required to break the wound
treated with cream B as compared to wound treated with cream A
and framycetin sulfate indicating that cream B was the most
effective among all three creams. Tensile strength of the animals
treated with standard (framycetin sulfate) was found to be greater
than tensile strength of the animals treated with cream A. This
indicates that framycetin sulfate cream has faster wound healing
rate than cream A.3.3. Excision wound model
The effect of wound healing activity in this model was evaluated
by determining the percent wound contraction and epithelializa-
tion period. The results in Table 2 are expressed as % wound
contraction and epithelialization period (mean ± SEM). The studies
on excision wound healing model revealed that both the groups
(cream A and B) showed decreased wound area from day 0 to day
20. On the 12th and 16th day, the % wound contraction of excision
wounds treated with cream A and B (95.43 ± 0.53 and
96.60 ± 1.16%, respectively) was found to be signiﬁcantly higher
(P < 0.05 and P < 0.01, respectively) than the wounds treated with
framycetin sulfate cream (92.00 ± 0.85%). The complete healing of
wound is seenwhen the eschar falls. Wounds treated with cream B
healed faster (day 17) and the healing was statistically signiﬁcant
(P < 0.001) as compared to the wounds treated with framycetin
sulfate (day 21).
The period of epithelization of wounds treated with cream A
was found to be low as compared to standard group. This indicates
that cream A and B promotes epithelialization of wound faster than
framycetin sulfate.4. Discussion
The wound healing process consists of different phases such as
granulation, collagenation, collagen maturation, and scar matura-
tion which are concurrent but independent of each other [24].
Therefore, it may not be possible to draw ﬁrm conclusion about the
inﬂuence of a given agent on healing by studying only one phase of
healing. Hence, in the present study, two different wound models
were used to evaluate the wound healing efﬁcacy of cream A and B
in comparison with framycetin sulfate cream in diabetic wound
models. The results of the present study showed that cream A and B
possessed a deﬁnite pro-healing action.
The results indicated that both the creams (cream A and B) did
not cause any skin reaction after examining at 24, 48, and 72 h. It
can be concluded that both the creams did not cause any skin
irritation and can be classiﬁed as non-irritant. Both the creams
were found to be safe for topical application.
In incision wound, the increase in the tensile strength of skin in
treated wounds may be due to increase in the collagen concen-
tration and stabilization of ﬁbers facilitating wound healing. The
highest tensile strength of the wounded skin was observed in the
animals treated with cream B.
Animals treated with cream A and B showed enhanced rate of
wound contraction and drastic reduction in healing time than
framycetin sulfate cream, which might be due to enhanced
epithelialization and cellular proliferation. This enhanced epithe-
lization may be due to the antioxidant effect of medicinal plants,
which augments collagen synthesis. The period of epithelization of
animals treated with creams A and B was less than framycetin
sulfate indicating faster wound healing. The animal treated with
cream B showed signiﬁcant results when compared with cream A
and standard.The results of the present study showed that the cream B
possessed signiﬁcant wound healing activity than cream A due to
the synergistic effects of Jatyadi Oil, C. asiatica, and other in-
gredients present in cream B. Asiaticoside isolated from C. asiatica
showed promising wound healing activity in normal as well as in
diabetic animals [25]. Jatyadi Oil is a classical Ayurvedic formula-
tion in oil form used for healing wounds. It is to be applied exter-
nally over non-healing wounds, sinus, blisters, abscess, and bite
wounds. It is also beneﬁcial in burn wounds. It possesses antimi-
crobial activity, due to that it acts as antiseptic and fungicidal. It is
also useful in various skin afﬂictions. Wound healing efﬁcacy of
Jatyadi Oil was also evaluated scientiﬁcally by in vivo evaluation in
rat using excision wound model [14].
5. Conclusion
Cream A and B were found to be non-irritant and safe for topical
application. Both cream A (Ari's Wound Healing Cream) and cream
B (Amarantha Wound Healing Cream) enhanced wound healing
process in albino rats when tested by incision and excision of fresh
and diabetic wound models. Thus, the prepared topical creams
possess multifaceted properties in healing the wound.
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